2 weeks Ago By ABMN Staff
Ainos, Inc. ( NASDAQ:AIMD – Get Free Report ) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 122,800 shares, a decrease of 27.
9% from the August 31st total of 170,400 shares. Approximately 8.4% of the shares of the stock are short sold.
Based on an average daily volume of 521,300 shares, the short-interest ratio is currently 0.2 days. Ainos Stock Down 5.
4 % Shares of AIMD opened at $0.50 on Friday. Ainos has a twelve month low of $0.
45 and a twelve month high of $4.29. The company has a current ratio of 1.
48, a quick ratio of 1.45 and a debt-to-equity ratio of 0.43.
The business’s 50-day moving average price is $0.60 and its 200-day moving average price is $0.87.
Ainos ( NASDAQ:AIMD – Get Free Report ) last announced its quarterly earnings results on Monday, August 5th. The company reported ($0.49) EPS for the quarter.
Ainos had a negative net margin of 15,348.14% and a negative return on equity of 64.54%.
Ainos Company Profile Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. Further Reading Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.
com's FREE daily email newsletter ..
